Glycomark
Assay, 1,5-Anhydroglucitol (15ag). 510(k) K031604, from Tomen America, Inc. (New York, NY). Product code NOZ, class 2.
As of Nov 19, 2026, K031604 is an FDA 510(k) held by Tomen America, Inc., substantially equivalent on Sep 22, 2003 after 123 days, with no recalls tied to it in FDA's recall database.
- Review time: 123 days
- Recalls: 0
- Cited as a predicate by: 1 device
The GlycoMarkâ„¢ test provides quantitative measurement of 1,5-anhydroglucitol (15AG) in serum or plasma. The test is for professional use, and is indicated for the intermediate term monitoring of glycemic control in people with diabetes.
- Tina-Quant Hemoglobin A1CK934070 · Boehringer Mannheim Corp. · Oct 11, 1994
- Diazyme 1,5-AG AssayK180209 · Diazyme Laboratories, Inc. · Oct 4, 2018
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 22, 2003
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files